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A fat-enriched diet modiﬁes intestinal microbiota and initiates a low-grade
inﬂammation, insulin resistance and type-2 diabetes. Here, we demonstrate that
before the onset of diabetes, after only one week of a high-fat diet (HFD), live
commensal intestinal bacteria are present in large numbers in the adipose tissue
and the blood where they can induce inﬂammation. This translocation is pre-
ventedinmice lacking themicrobial pattern recognition receptorsNod1 orCD14,
but overtly increased in Myd88 knockout and ob/ob mouse. This ‘metabolic
bacteremia’ is characterized by an increased co-localization with dendritic cells
from the intestinal lamina propria and by an augmented intestinal mucosal
adherence of non-pathogenic Escherichia coli. The bacterial translocation process
from intestine towards tissue can be reversed by six weeks of treatment with the
probiotic strain Biﬁdobacterium animalis subsp. lactis 420, which improves the
animals’ overall inﬂammatory and metabolic status. Altogether, these data
demonstrate that the early onset of HFD-induced hyperglycemia is characterized
by an increased bacterial translocation from intestine towards tissues, fuelling
a continuous metabolic bacteremia, which could represent new therapeutic
targets.
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Over the last decades, the incidence of diabetes and obesity has
risen dramatically and this unabated increase can be justly
describedasaworld-wideepidemic.Adramaticchangeindietary
habits, characterized by an increased intake of lipids, has been
suggested to be mainly responsible for the dramatic rise in
metabolicdiseasesthroughmechanisms,whichinducelowgrade
inﬂammation (Hotamisligil, 2006; Shi et al, 2006; Shoelson et al,
2006). TNF-a continuously released by the adipose tissue during
obesity has been shown to activate protein kinase C (PKC) and to
increase the phosphorylation of insulin receptor substrates on
serine residues such as Ser-307, leading to the inactivation of this
insulin signalling molecule and hence to insulin resistance (Tanti
et al, 2004). However, the origin of the antigens responsible for
the inﬂammatory process has not been described. Recently, the
causal role of the intestinal microbiota in weight gain has been
demonstrated in experiments in which germ-free mice colonized
with the intestinal microbiota from genetically obese ob/ob mice
gained more weight than their counterparts colonized with
microbiota from lean animals. Hence, obesity could be
transferred by the intestinal microbiota (Backhed et al, 2004,
2005; Ley et al, 2005, 2006; Turnbaugh et al, 2006, 2007).
Altogether,thesedatademonstratedthattheintestinalmicrobiota
and the interactions between the host and the microbiota are
involvedinthecontrolofenergymetabolism.Akeyquestionisto
understand the mechanism through which the intestinal
microﬂora could speciﬁcally affect tissue inﬂammation. An
important observation in this respect is that intestinal phagocytes
such as dendritic cells and macrophages capture bacterial
intestinal antigens and transfer them into lysosomes for
degradation (Sansonetti & Di Santo, 2007), thereby providing a
directcellularlinkbetweentheintestinalmicrobiotaandthehost,
named bacterial translocation. This process requires bacterial
antigen receptors such as toll-like receptors (TLR) (Keita et al,
2008; Neal et al, 2006) and nod-like receptors (NLR) (Kufer et al,
2008), through which viable and dead bacteria and their
components initiate the activation of innate immune cells.
Furthermore, cells from the innate immune system inﬁltrate the
adipose depots during metabolic diseases (Weisberg et al, 2003,
2006). Therefore, we suggest that during high-fat diet-induced
diabetes, commensal intestinal bacteria translocate in a patho-
logical manner from the intestine towards the tissues where they
trigger a local inﬂammation.
The present data show for the ﬁrst time that during the early
onset of high-fat diet-induced diabetes, bacteria from the
intestine are actively translocated into the mesenteric adipose
tissue (MAT) and the blood. This translocation initiates a ‘low
gradebacteremia’ whichdependsonCD14,Nod1,butnotNod2.
It is further regulated by leptin, which identiﬁes a new function
for this hormone. This metabolic bacteremia was reversed by a
treatment using the probiotic strain Biﬁdobacterium animalis
subsp. lactis 420, which reduced the mucosal adherence and
bacterial translocation of gram-negative bacteria from the
Enterobacteriaceae group. Consequently, adipose tissue inﬂam-
mation and several features characteristic of diabetes were
normalized. Therefore, the control of intestinal bacterial
translocation and mucosal dysbiosis could be considered as a
new therapeutic strategy for the control of high-fat diet-induced
diabetes and metabolic syndrome.
RESULTS
High-fat feeding increases the translocation of live gram-
negative bacteria through intestinal mucosa to blood and
mesenteric adipose tissue
To determine which tissues are targeted by the bacterial
translocation, we ﬁrst quantiﬁed the bacterial 16S rRNA DNA
concentration in different tissues. The data show that bacterial
DNA is detectable in the blood of normal chow fed mice (Fig 1A
and D, Supporting information Fig S1A and C). However, there
was roughly 1000 and 2000–10,000 times less bacterial DNA in
MAT and blood, respectively, when compared to cæcal content
(Supporting information Fig S1A). The overall microbial
population was also evaluated by denaturing gradient gel
electrophoresis (DGGE) analysis, and the number of bands
showed that microbiota is less diverse in tissues than in the gut
(Supporting information Fig S1B and C).
To follow the bacterial translocation from intestine, a possible
mechanism for the existence of bacterial DNA of intestinal origin
found in tissues, we generated a ﬂuorescently labelled,
ampicillin-resistant Escherichia coli (GFP-E. coli) from a mouse
E. coli. After only 1 week of a high-fat diet (HFD), GFP-E. coli was
gavaged to mice. As a result, the colony forming units (cfu)
equivalent of ﬂuorescent E. coli (as quantiﬁed by RT-qPCR) was
increasedinblood,2hafter gavage,whencomparedwithnormal
chow (NC)-fed mice (Supporting information Fig S2C). This was
similar towhatwasobservedfor wild-typeE.coli DNA quantiﬁed
by speciﬁc E. coli 16S qPCR already present in blood (Supporting
information Fig S2B), total gram-negative bacteria DNA (Sup-
porting information Fig S2A), and for total bacteria (Fig 1A).
After 4 weeks of HFD, when the diabetic state is established
(Cani et al, 2008, 2009), the amounts of total bacterial DNA
(Fig 1A), gram-negative bacterial DNA (Supporting information
FigS2A), andE. coli DNA (Supporting information FigS2B)were
still increasing in blood. We also quantiﬁed total bacterial DNA
in MAT and in the corresponding mesenteric lymph nodes
(MLN),sinceinnateimmunecells,whichweresuspectedtohave
phagocytosed translocated intestinal bacteria, could accumulate
in this tissue. After 1 week of HFD, the amount of bacterial DNA
was increased in MAT but not in MLN (Fig 1B and C), and a
similar observation was made in regard to the cfu quantiﬁcation
from ampicillin-resistant E. coli in these tissues 2h after gavage
(Supporting information Fig S2D). Once the diabetic state was
established (4 weeks HFD), the amount of bacterial DNA was
increased in both MAT and MLN (Fig 1B and C).
Translocation of intestinal bacteria, glucose metabolism and
body weight are regulated by Nod1, leptin, Myd88 and CD14
We analysed ﬁrst whether Nod1 and Nod2 were involved in the
accumulation of tissue bacteria during HFD. When the Nod1
 / 
mice were fed with HFD for 1 month, fasting glycemia and
glucose tolerance (Fig 2A and C), fat mass (Fig 2D) and body
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concentration (Fig 2E), and whole body insulin-sensitive
glucose turnover rate (Fig 2F) were strictly similar between
NC- and HFD-fed Nod1
 /  mice as well as wild-type (WT) mice
fed a normal chow, while WT mice fed a HFD were clearly
sensitive to the dietary treatment for all parameters (Fig 2A, C,
D, E and F, Supporting information Fig S3A). Conversely,
Nod2
 /  mice were still sensitive to HFD for all parameters
studied (Fig 2B–F, Supporting information Fig S3A).
We also previously showed that CD14
 /  mice resist the
diabetic and obese phenotypes in response to HFD (Cani et al,
2008). We therefore mated leptin-deﬁcient mice with CD14
 / 
mice, as described (Cani et al, 2008). In the double mutant mice,
fasted glycemia and glucose tolerance (Fig 2G and H) as well as
the fat mass percentage and whole body weight (Fig 2I,
Supporting information Fig S3B) were improved when com-
pared to the single mutant ob/ob mice.
Myd88 is one of the major signalling molecules involved in
TLR activation (except activation of TLR3). Therefore, we
compared the corresponding mutant mice with WT mice and
showed that fasted glycemia and glucose intolerance (Fig 3A),
body weight (Fig 3B), fat mass (Fig 3C), plasma insulin (Fig 3D)
and insulin resistance (Fig 3E) were increased when compared
to the corresponding WT mice.
Total bacterial DNA concentration, in blood and MAT, was
unchanged or even reduced in Nod1
 /  mice after HFD
treatment, whereas it was conversely increased in Nod2
 / 
mice(Fig1DandE,andcomparewithwild-typemiceFig1Aand
B). The absence of leptin increased the total amount of bacterial
DNA in blood (Fig 1F compared with Fig 1A) and MAT (Fig 1G
compared with Fig 1B). A similar observation was made when
GFP-E. coli was quantiﬁed in MAT 2h following the gavage
(Supporting information Fig S2E). In addition, the absence of
CD14 in leptin-deﬁcient mice decreased the bacterial DNA
content in blood and MAT (Fig 1F and G), as well as the cfu
count of GFP-E. coli in MAT 2h after gavage (Supporting
information Fig S2E) compared with ob/ob mice. In Myd88-
deleted mice, the translocation of living E. coli (Fig 3F) and the
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Figure 1. High-fat diet increases the
concentration of bacterial DNA in blood,
mesenteric adipose tissue (MAT), and
corresponding lymph nodes (MLN) before the
onset of diabetes. The pathogen recognition
receptors Nod1 and CD14, but not Nod2, control
high-fat diet-induced bacterial DNA accumulation
in tissues. The regulatory role of leptin.
16S rRNA DNA concentration (pg/mg total DNA;
qPCR):
A,B,C. From total bacteria in blood (A), MAT (B) and
MLN(C) ofnormal chow(NC)-fed, prediabetic
(HFD 1 week), and diabetic mice (HFD 4
weeks) (mean SEM; n¼8).
D,E. From total bacteria in blood (D), and MAT (E)
of Nod1-deficient mice (Nod1
 / ), and Nod2-
deficient mice (Nod2
 / ), after 4 weeks of a
normal chow (NC) or a high-fat diet (HFD 4
weeks) (mean SEM; n¼11).
F,G. From total bacteria in blood (F), and MAT (G),
of ob/ob, ob/obxCD14
 / , and CD14
 /  mice
(all NC-fed) (mean SEM; n¼8).
Data with identical superscript letters (A–G)
do not differ from each other with p>0.05.
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increased in MAT compared with WT mice.
High-fat feeding increases the adherence of a gram-negative
bacteria species to intestinal mucosa and its co-localization
with dendritic cells in lamina propria and mesenteric lymph
nodes
Two hours after gavage with GFP-E. coli, adherence of the
bacteria to mucosal surface of duodenum, jejunum, ileum and
cæcum was increased in mice fed with a HFD for only 1 week,
when compared with normal chow-fed mice (Fig 4A), while after
5h the difference was more evident in cæcum (Supporting
informationFigS4A).Importantly,1weekofHFDisnotsufﬁcient
to induce diabetes showing that bacterial translocation precedes
the occurrence of diabetes. This increased adherence of GFP-E.
coli to mucosa persisted signiﬁcantly in ileum and cæcum until
the 4th week of HFD (Fig 4A), by which time HFD-fed mice have
developed diabetes. In addition, examination by ﬂuorescence
microscopyofileal mucosaobtainedbyscraping2hafter the oral
gavage, conﬁrmed the presence of ﬂuorescent E. coli mainly in
ileal mucosa of HFD-fed mice (Fig 4B and C). This was similar,
although to a lower extent, after 5h (Supporting information Fig
S4B and C). Fluorescent bacteria could also be detected in
sections of ileum, inside lamina propria, 2h post-gavage (Fig 4D)
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Figure 2. ThepathogenrecognitionreceptorsNod1andCD14,butnotNod2,controlhigh-fatdiet-inducedglucoseintolerance,diabetesandfatmassgain.
The regulatory role of leptin.
A,B,C. Oral glucose tolerance test (OGTT) (1.5g/kg) in Nod1-deficient mice (Nod1
 / ) (A), Nod2-deficient mice (Nod2
 / ) (B) and their corresponding wild-type
controls (WT) after 4 weeks of a normal chow (NC) or a high-fat diet (HFD) and corresponding index (mM/min) from 15 to 120min after glucose
administration (C) (mean SEM; n¼11;
 p<0.05; data with identical superscript letters do not differ from each other with p>0.05).
D,E,F. Fat mass (% of body weight; EchoMRI) (D), fasted plasma insulin (mU/ml) (E) and insulin sensitivity (glucose turnover rate in mg/kgmin) (F), in Nod1
 /  or
Nod2
 /  mice and their corresponding WT controls after 4 weeks of a NC or a HFD (mean SEM; n¼11 (D); 8 (E); or 5 (F); data with identical superscript
letters do not differ from each other with p>0.05).
G. Intraperitoneal glucose tolerance test (IPGTT) (1g/kg) in WT, ob/ob, ob/obxCD14
 /  and CD14
 /  mice (all NC-fed) (mean SEM; n¼8;
 p<0.05 versus ob/
ob).
H. IPGTT correspondingindex(mM/min) from30minbeforeto90minafterglucoseadministration (mean SEM;n¼8;datawithidenticalsuperscriptletters
do not differ from each other with p>0.05).
I. Fat mass (% of body weight; EchoMRI) in WT, ob/ob, ob/obxCD14
 /  and CD14
 /  mice (all NC-fed) (mean SEM; n¼8; data with identical superscript
letters do not differ from each other with p>0.05).
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Fig S4D). The number of transmucosal GFP-E. coli was estimated
to be 5–10 times higher, 2 and 5h post-gavage in HFD-fed mice
compared to normal chow-fed mice (Fig 4E, Supporting
information Fig S4E).
After 4 weeks of HFD, when the diabetic state is established
(Burcelin et al, 2002; Cook et al, 2004), we were able to detect
co-localization of ﬂuorescent bacteria with dendritic cells (DC)
in the lamina propria. In normal chow-fed mice, DC were
restricted inside the lamina propria, whereas after 4 weeks of
HFD, DC were also seen between enterocytes, extending large
dendrites towards the intestinal lumen. Importantly, ﬂuorescent
E. coli could be co-localized with CD11c-positive cells, i.e. DC,
on the luminal side of villi and in lamina propria. These co-
localizations were detected in HFD-fed mice only (Fig 4F). The
percentage of DC that co-localized with ﬂuorescent E. coli was
estimated to be between 5 and 10% of all DC in lamina propria
2h post-gavage in HFD-fed mice, whereas no co-localization
was detectable in normal chow-fed controls (Fig 4G).
Interestingly, ﬂuorescent E. coli also co-localized with DC in
MLN, although to a lower extent than what was observed in the
lamina propria (Fig 4H). The percentage of DC co-localizing
withﬂuorescentE.coliinMLNwasalsoestimatedtobebetween
5 and 10% 2h post-gavage in HFD-fed mice, while they were
undetectable in normal chow-fed animals (Fig 4I).
To analyse whether there was a differential distribution of
intestinal microbiota in the intestine, we quantiﬁed the mucosal
and luminal bacterial DNA content by qPCR and showed that
1 week of HFD increased the microbial population in the lumen
and the mucosa (Fig 5A). This was further reinforced in the
mucosa after 4 weeks of HFD. The expression of markers of
inﬂammation was quantiﬁed in MAT and showed a moderate,
but signiﬁcant increase after 4 weeks of HFD for TNF-a and IFN-
g (Fig 5B). Moreover, MAT TNF-a mRNA concentration was the
only marker, which positively correlated with the luminal and
mucosal bacterial content (Fig 5C and D).
Intestinal leptin delivery regulates intestinal bacterial
adherence, translocation and metabolism
An increased bacterial translocation was characteristic for the
ob/ob mice. To determine whether leptin regulates bacterial
translocation, we administered a probiotic, which produces and
releases leptin (Lactococcus lactis leptin) aiming to target
intestinal metabolism. We treated HFD and ob/ob mice for
8 weeks. In the leptin-deﬁcient mice, the circulating leptin
concentration remained undetectable suggesting only a possible
local effect of the leptin-producing probiotic. Body weight gain
(Fig 6A) and fat mass gain (Fig 6B) were reduced over the time
course of the treatment. Glucose intolerance (Fig 6C and D) was
slightly reduced although fasted plasma insulin concentration
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Figure 3. Metabolic disturbances and increased
bacterial translocation to mesenteric adipose tissue
(MAT) in Myd88 knockout mice.
A. Intraperitoneal glucose tolerance test (IPGTT)
(1g/kg) in Myd88-deficient mice (Myd88
 / )
and their corresponding wild-type controls
(WT) feda normal chow(NC) diet(mean SEM;
n¼7;
 p<0.05 versus controls).
B,C,D,E. Body weight (B), fat mass (% of body weight;
EchoMRI) (C), fasted plasma insulin (mU/ml) (D)
and insulin sensitivity (glucose turnover rate in
mg/kgmin) (E), in Myd88
 /  mice and their
corresponding WT controls fed a NC diet
(mean SEM; n¼5; data with identical
superscript letters do not differ from each other
with p>0.05).
F. Number of GFP-E. coli cfu per g of MAT in
Myd88
 /  mice and their corresponding WT
controls fedaNC diet, 2hpost-gavagewith10
9
cfu of GFP-E. coli (mean SEM; n¼7; data with
identical superscript letters do not differ from
each other with p>0.05).
G. 16S rRNA DNA concentration (pg/mg total DNA;
qPCR) from total bacteria in MAT of Myd88
 / 
mice and their corresponding WT controls fed a
NCdiet(mean SEM;n¼7; datawithidentical
superscript letters do not differ from each other
with p>0.05).
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a dramatic reduction in the mucosal/lumen ratio of adherent
GFP-E. coli in the ileum only, whereas no change in the cæcum
were observed (Fig 6F). Bacterial translocation of live bacteria
was reduced by the leptin treatment (Fig 6G) while total dead
and live bacteria remained unaffected (Fig 6H). This was
associated with a modest reduction of adipose tissue inﬂamma-
tion as shown by the reduction of the concentration of some
cytokine mRNAs (Fig 6I). In a second set of experiments, ob/ob
mice were treated similarly. Body weight gain (Fig 7A) and fat
massgain(Fig 7B),fastedglycemia(Fig7C), glucoseintolerance
(Fig 7C and D), and fasted plasma insulin concentration (Fig 7E)
were reduced by the leptin treatment. The mucosal bacterial
adherence (Fig 7F), the content of live GFP-E. coli in MAT
(Fig7G),andbacterialmRNA(Fig7I)werereducedby theleptin
treatment, whereas the total bacterial content remained the
same in MAT (Fig 7H). The mRNA concentration of some
(PAI-1, IL-6), but not all (TNF-a, IL-1b, IFN-g), inﬂammatory
markers was reduced in the mesenteric adipose depot of mice
treated with leptin (Fig 7J).
A probiotic treatment reduces mucosal dysbiosis, bacterial
translocation and improves glucose metabolism
To determine if a change in bacterial translocation could affect
HFD-induced diabetes, we treated mice with the probiotic
Biﬁdobacterium animalis subsp. lactis 420 (B420) (Supporting
information Fig S5A), previously shown to bind to and exclude
pathogenic bacteria from intestinal mucosa in vitro (Collado
et al, 2007; Collado & Sanz, 2007). A 1-month daily treatment of
HFD-induced diabetic mice with 10
9cfu of B420 effectively
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Figure 4. Intestinal mucosal adherence and
transmucosal passage of bacteria are increased
during high-fat diet (HFD) treatment before the onset
of diabetes, and intestinal bacteria co-localize with
dendritic cells of lamina propria and mesenteric
lymph nodes (MLN).
A. Bacterial adherence (GFP-E. coli cfu per cm of
mucosa/GFP-E. coli cfu per cm of lumen) in normal
chow (NC)-fed (Control NC), prediabetic (HFD 1
week), and diabetic mice (HFD 4 weeks), 2h after
gavage with 10
9 cfu of GFP-E. coli (Duo, duodenum;
Jej, jejunum; Ile, ileum; Cæ, cæcum) (mean SEM;
n¼10–12; data with identical superscript letters
do not differ from each other with p>0.05).
B. Fluorescence microscopy of scrapped ileal mucosa
from NC-fed (Control NC) and prediabetic mice
(HFD 1 week), 2h after gavage with 10
9 cfu of GFP-
E. coli. Bars¼20mm.
C. Corresponding number of GFP-E. coli/mm
2 of
scrapped ileal mucosa (fluorescence microscopy)
(mean SEM; n¼6; data with identical superscript
letters do not differ from each other with p>0.05).
D. Fluorescence microscopy of DAPI-counterstained
cryosections of ileum from NC-fed (Control NC) and
prediabetic mice (HFD 1 week), 2h after gavage
with 10
9 cfu of GFP-E. coli. Right panel corresponds
to magnification of surrounded region.
Bars¼20mm.
E. Corresponding number of transmucosal GFP-E. coli/
mm
2 of ileum section (fluorescence microscopy)
(mean SEM; n¼6; data with identical superscript
letters do not differ from each other with p>0.05).
F,H. Immunofluorescent labelling of CD11c-positive
cells [dendritic cells (DC) in red] and co-localization
with fluorescent GFP-E. coli (green) on DAPI-coun-
terstained (nuclei in blue) cryosections of ileum (F),
and MLN (H), from NC-fed (Control NC), and dia-
betic mice (HFD 4 weeks), 2h after gavage with 10
9
cfu of GFP-E. coli. Arrows point co-localizations
(yellow). Right panels correspond to magnification
of surrounded regions. Bars¼20mm.
G,I. Corresponding quantification of CD11c-positive
cells co-localized with GFP-E. coli (% of total DC) in
ileum (G) and MLN (I) (mean SEM; n¼6; data
with identical superscript letters do not differ from
each other with p>0.05).
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intestine mucosa (Fig 8A and B). Concomitantly, the quantity of
Biﬁdobacterium spp. was slightly, although not signiﬁcantly,
increased in ileal mucosa (Supporting information Fig S5B). We
further analysed some of the major bacterial groups in MAT and
showed that the number of Enterobacteriaceae, which was
strongly increased in mice fed with a HFD when compared to
normal chow-fed controls, was decreased by the probiotic
treatment whereas the other groups were mostly unaffected
(Fig 8C). Biﬁdobacterium spp. was not detected in MAT at any
time point. In addition, the expression of the major pro-
inﬂammatory cytokines TNF-a, IL-1b, PAI-1 and IL-6, was
reduced inMAT, liverand muscle of treated HFD-fed mice when
compared with untreated HFD-fed control mice (Fig 8D,
Supporting information Fig S5C and D). The probiotic treatment
also impacted on the overall metabolism since glucose
intolerance was moderately blunted although fasting glycemia
remained unaffected (Supporting information Fig S5E). In
addition, insulin sensitivity and fasting hyperinsulinemia were
completely normalized by the probiotic treatment (Fig 8E,
Supporting information Fig S5F).
DISCUSSION
We have identiﬁed for the ﬁrst time that adipose tissue and
blood from diabetic mice fed with HFD contain live bacteria,
which originate from intestine and are linked to low-grade
inﬂammation. Nod1, CD14 and Myd88 are required for this
process. Furthermore, leptin inhibits mucosal bacterial adher-
ence and the translocation of live bacteria from the intestine
towards tissues. At the early onset of diabetes, we further
showed that intestinal bacteria from the lumen reach the
mucosal layer where dendritic cells may phagocytose the
bacteria, which then may migrate inside the body towards
metabolically active tissues. Importantly, a probiotic treatment,
which prevents bacterial adherence and translocation, protects
also against HFD-induced inﬂammation, insulin resistance and
diabetes.
It is now well accepted that HFD-induced metabolic diseases
are associated with a low-grade inﬂammation occurring, among
other tissues, in adipose depots. This inﬂammatory process is
characterized by an increased production of cytokines and
inﬁltration of macrophages (Weisberg et al, 2003, 2006).
Furthermore, the genetic deletion of the tissue inhibitor of
metalloproteinase 3 (Timp3), which is a natural inhibitor of
tumour necrosis factor-alpha-converting enzyme (TACE) (Ser-
ino et al, 2007), has been recently shown to catalyse HFD-
induced metabolic diseases (Federici et al, 2005; Menghini et al,
2009). Therefore, these data reinforce the role of inﬂammation
as an early factor responsible for insulin resistance before the
onset of obesity. The nature of antigens present in adipose
depots and responsible for the inﬂammatory process is not fully
understood. In light of the recently increasing amount of data
showing the role of intestinal microﬂora in the control of
metabolic diseases, we determined here themicrobial content of
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Figure 5. TNF-a expression in mesenteric adipose
tissue (MAT) correlates positively with bacterial DNA
concentration in ileum before the onset of high-fat
diet-induced diabetes.
A. 16S rRNA DNA concentration (ng/mg total DNA;
qPCR) from total bacteria in mucosa and lumen of
ileum, in normal chow (NC)-fed, prediabetic (HFD 1
week), and diabetic mice (HFD 4 weeks) (mean
 SEM; n¼6; data with identical superscript
letters do not differ from each other with p>0.05).
B. Concentration of mRNA coding for the inflamma-
tory markers TNF-a, IL-1b, PAI-1, IL-6 and IFN-g in
MAT of normal chow (NC)-fed, prediabetic and
diabetic mice (RT-qPCR) (mean SEM; n¼6; data
with identical superscript letters do not differ with
p>0.05; expressions of the different markers were
not compared between themselves).
C,D. Correlations between TNF-a expression in MAT and
bacterial concentration (ng 16S rRNA DNA/mg total
DNA; qPCR), of ileal lumen (C), and ileal mucosa (D),
in NC-fed, prediabetic (HFD 1 week), and diabetic
mice (HFD 4 weeks).
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E. coli from mouse intestinal microbiota and labelled it with a
ﬂuorophore and an ampicillin reporter gene. As quickly as 2h
after gavage with ﬂuorescent E. coli this commensal bacterium
dramaticallyaccumulatedinmucosaofthedifferentsegmentsof
intestine of HFD-fed mice only. This was also true for the overall
bacterial content, suggesting that the intestinal mucosa from
HFD-fed mice exhibits properties, which are different from the
mucosa of normal chow-fed mice and which facilitate the
bacterial adherence. Indeed, leptin resistance could lead to an
impaired intestinal barrier function since the hormone mod-
ulates the expression of secreted and membrane-associated
mucins in colonic epithelial cells by targeting PKC, phosphoi-
nositide 3-kinase (PI3K), and mitogen-activated protein kinase
(MAPK) pathways (El Homsi et al, 2007).
Although the mechanismofmucosal adherence remains tobe
elucidated, the accumulation of bacteria close to the mucosa
could certainly facilitate their translocation through the
epithelium. We analysed this last hypothesis and showed that
HFD led to an increase in the E. coli co-localization with DC in
the intestinal lamina propria. The bacteria, probably remaining
inside DC, then rapidly disseminated into MAT and correspond-
ing MLN where again the ﬂuorescent E. coli co-localized with
DC. The putative rate-limiting role of DC cannot be fully and
causally explored in this model of bacterial translocation.
However, their role in the control of glucose metabolism has
been demonstrated elsewhere (Macia et al, 2006; Nguyen et al,
2007) by means of the secretion of CXCL14 required for the
regulatory role of DC on lymphocytes (Hara & Nakayama, 2009)
and for other inﬂammatory diseases such as inﬂammatory
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Figure 6. Probiotic-mediated intestinal leptin
delivery reverses high-fat diet (HFD)-metabolic
disturbances, bacterial adherence and translocation,
and mesenteric adipose tissue (MAT) inflammation.
HFD-fed WT mice were orally treated with 10
9cfu/day of
leptin-producing Lactococcus lactis (L. lactis leptin) and
their corresponding controls orally treated with 10
9cfu/
day of Lactococcus lactis (L. lactis).
A,B. Body weight gain (% of initial weight) (A), fat
mass change during treatment in % of body
weight (EchoMRI) (B) (mean SEM; n¼6;
 p<0.05versuscontrols(A);datawithidentical
superscript letters do not differ from each other
with p>0.05 (B)).
C,D. Oral glucose tolerance test (OGTT) (1.5g/kg) (C),
andcorrespondingindex(mM/min)from30min
before to 120min after glucose administration
(D) (mean SEM; n¼6;
 p<0.05 versus con-
trols (C); data with identical superscript letters
do not differ from each other with p>0.05 (D)).
E,F,G,H. Fed plasma insulin (mU/ml) (E), GFP-E. coli
adherence (GFP-E. coli cfu per cm of mucosa/
GFP-E. coli cfu per cm of lumen) in ileum and
cæcum, 2h post-gavage with 10
9 cfu of GFP-E.
coli (F), number of GFP-E. coli cfu per g of MAT,
2h post-gavage with 10
9 cfu of GFP-E. coli (G),
and 16S rRNA DNA concentration (pg/mg total
DNA; qPCR) from total bacteria in MAT (H)
(mean SEM; n¼6; data with identical
superscript letters do not differ from each other
with p>0.05).
I. Concentration of mRNA coding for the
inflammatory markers TNF-a, IL-1b, PAI-1, IL-6
and IFN-g in MAT (RT-qPCR) (mean SEM;
n¼6; data with identical superscript letters do
not differ with p>0.05; expressions of the
different markers were not compared between
themselves).
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the presence of various bacteria in MAT and the corresponding
MLN represents a physiological mechanism that is exacerbated
during HFD-induced metabolic diseases. It is noteworthy that
HFD increases the accumulation of gram-negative bacteria that
produce lipopolysaccharides (LPS), which are highly inﬂam-
matogenic molecules. Therefore, our data show that this
metabolic translocation of gram-negative bacteria and LPS
provides a rationale for HFD-induced inﬂammation and insulin
resistance. We previously documented that in humans and
mice, an increased proportion of fat in the diet moderately
augmented, by two to three times, the plasma concentration of
gram-negative bacteria cell wall components LPS (Amar et al,
2008; Cani et al, 2007a). Hence, we described this increase in
plasmaLPSas’metabolic endotoxemia’. In addition, weshowed
thatantibioticsanddietaryﬁbres,mostlikelyactingbychanging
the intestinal microbiota of HFD-fed mice, can reduce metabolic
endotoxemia, inﬂammation, and improve the overall impaired
metabolism (Cani et al, 2007b, 2008; Membrez et al, 2008).
The mechanisms through which bacterial factors could reach
adipose tissue are unknown but there could be several
hypotheses. Firstly, we initially suggested that a HFD is
associated with an increased intestinal tight junction perme-
ability (Cani et al, 2008, 2009) by which bacterial fragments
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Figure 7. Probiotic-mediated intestinal leptin
delivery reverses metabolic disturbances, bacterial
adherence and translocation, and mesenteric adipose
tissue (MAT) inflammation in ob/ob mice. ob/ob mice
were orally treated with 10
9 cfu/day of leptin-producing
Lactococcus lactis (L. lactis leptin) and their
correspondingcontrolsorallytreated with10
9cfu/dayof
Lactococcus lactis (L. lactis).
A,B. Body weight gain (% of initial weight) (A), fat
mass change during treatment time course
(%ofbody weight; EchoMRI)(B)(mean SEM;
n¼6;
 p<0.05 versus controls (A); data with
identical superscript letters do not differ from
each other with p>0.05 (B)).
C,D. Intraperitoneal glucose tolerance test (IPGTT)
(1g/kg) (C), and corresponding index (mM/
min) from 30min before to 90min after glu-
cose administration (D) (mean SEM; n¼6;
 p<0.05 versus controls (C); data with iden-
ticalsuperscriptlettersdonotdifferfromeach
other with p>0.05 (D)).
E,F,G,H,I. Fed plasma insulin (mU/ml) (E), GFP-E. coli
adherence (GFP-E. coli cfu per cm of mucosa/
GFP-E. coli cfu per cm of lumen) in ileum and
cæcum, 2hpost-gavage with10
9cfu ofGFP-E.
coli (F), number of GFP-E. coli cfu per g of MAT,
2h post-gavage with 10
9 cfu of GFP-E. coli (G),
16S rRNA DNA concentration (pg/mg total
DNA;qPCR)fromtotalbacteriainMAT(H),16S
rRNA concentration (pg/mg total RNA; RT-
qPCR) from total bacteria in MAT (I) (mean
 SEM; n¼6; data with identical superscript
letters do not differ from each other with
p>0.05).
J. Concentration of mRNA coding for the
inflammatory markers TNF-a, IL-1b, PAI-1,
IL-6 and IFN-g in MAT (RT-qPCR, 2
 DDCt)
(mean SEM; n¼6; data with identical
superscript letters do not differ with p>0.05;
expressions of the different markers were not
compared between themselves).
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intestinal bacteria through the intestinal epithelium could be
exacerbated during the development of metabolic diseases.
Similarly, commensal bacteria have been proposed to translo-
cateintothehostmammaryglandsviaMLNandPeyer’spatches
inlactatingmice(Haseetal,2009;Perezetal,2007;Sansonetti&
Phalipon, 1999).
Intraluminal microbial detection requires the recognition of
pathogen-associated molecular patterns (PAMPs) by pattern
recognition receptors (PRRs) that are distributed on the cell
surface and within the cytosol of innate immune cells. Toll-like
receptors (TLRs) and nucleotide-binding oligomerization
domain (Nod)-like receptor (NLRs) families function as
extracellular and intracellular PRR, respectively, that trigger
innate immune responses (Kufer & Sansonetti, 2007; Lundin et
al, 2008). Therefore, molecular signalling during the bacterial
translocation process could involve both the LPS receptors
CD14/TLR4 and intracellular receptors for various other
antigens such as Nod1 and Nod2 (Fritz et al, 2007; Kufer &
Sansonetti, 2007). In this study, we showed that in absence of
Nod1 but not Nod2, a HFD could no longer induce glucose
intolerance and diabetes, suggesting that Nod1, which detects
D-glutamyl-meso-diaminopimelic acid (meso-DAP)-containing
peptidoglycan (PGN) found principally in gram-negative
bacteria, was required for the control of metabolic diseases.
The bacterial translocation process was reduced accordingly.
Similar results were obtained in CD14 knockout mice. In
agreement with other reports (Paulos et al, 2007), the
internalization of gram-negative bacteria through intestinal
epithelium in vivo and their transport towards MAT and MLN
was signiﬁcantly lower in mice with the LPS co-receptor CD14
deletion when compared with wild-type (WT) mice. Our data
demonstrate that the recognition of bacterial fragments by
specialized cells is mandatory for the induction of inﬂammation
and the triggering of metabolic disease. Furthermore, the fact
that both CD14 and Nod1 were necessary for the induction of
diabetes in response to the fat-enriched diet suggests that a
crosstalk between the two non-redundant pathways might be
involved, which synergizes for a full inﬂammatory response
to the translocated gram-negative bacteria. Myd88 is a good
candidate; however, surprisingly the intolerance to glucose as
well as the fasted glycemia were higher in the knock-out model
than in wild-type mice. This phenotype was associated with an
increased bacterial translocation. This last set of data suggests
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Figure 8. AprobiotictreatmentwithBifidobacteriumlactis420reverseshigh-fatdiet(HFD)-inducedbacterialadherenceandtranslocation,adiposetissue
(MAT) inflammation and insulin resistance.
A,B. Luminal (A) and mucosal (B) number of colony forming units (cfu) per cm of duodenum (Duo), jejunum (Jej), ileum (Ile), and cæcum (Cæ), 2h following oral
gavage with 10
9 cfu of GFP-E. coli.) (mean SEM; n¼8; data with identical superscript letters do not differ with p>0.05).
C. Difference in major groups of bacteria in MAT (qPCR), between HFD and NC groups (left panel), and HFDþB420 and HFD groups (right panel) (mean SEM;
n¼8;
 p<0.05).
D. Concentration of mRNA coding for the inflammatory markers TNF-a, IL-1b, PAI-1 and IL-6 in MAT (RT-qPCR) (mean SEM; n¼8–10; data with identical
superscript letters do not differ with p>0.05; expressions of the different markers were not compared between themselves).
E. Insulin sensitivity (glucose turnover rate in mg/kgmin). (mean SEM; n¼8–10; data with identical superscript letters do not differ with p>0.05).
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protecting from HFD-induced metabolic diseases. Our data
suggest that conversely to Nod1, Nod2 could be associated with
this protective function and hence the ablation of Myd88 would
prevent the protecting role of Nod2.
Other antigen receptors such as the nucleotide-binding
domain, leucine-rich-containing family, pyrin domain-contain-
ing-3 (Nlrp3) inﬂammasome, belonging to the NLR family, could
also be involved in bacterial translocation. Nlrp3 inﬂammasome
senses lipotoxicity-associated increases in intracellular ceramide
to induce caspase-1 cleavage in macrophages and adipose tissue
(Stienstra et al, 2010; Vandanmagsar et al, 2011). Therefore,
complex lipids of bacterial origin could trigger inﬂammation
through the binding of Nlrp3. Hence, our data sets the scene
for the discovery of numerous other receptors involved in
the triggering of inﬂammation in response to a fat-enriched
diet.
Our data support a similar conclusion regarding body weight
gain.Thisconclusionisfurtherreinforcedbythefactthatobese/
diabetic ob/ob mice are also characterized by an increased
bacterial translocation as described here. Therefore, this
mechanism does not seem to be restricted to HFD but more
widely distributed in different animal models. Furthermore,
deletion of CD14 within ob/ob mice reduced bacterial transloca-
tion and improved the metabolic and inﬂammatory phenotypes
as previously described (Cani et al, 2008). These data also
demonstrate a new role for leptin: the control of intestinal
bacterial translocation. Importantly, leptin regulates the trans-
location of live bacteria into the tissues since the local intestinal
leptin treatment did not reduce the total tissue content of
whole bacteria. Our data also suggest that the role of leptin on
intestinalbacterialadherenceandtranslocationisdirectedtothe
intestine. The treatment using the leptin-producing probiotic
did not modify the circulating leptin concentration, suggesting
that the hormone had a role on the intestinal metabolism.
However, we cannot rule out that this original role of leptin
might be indirect through its effect on body weight or other of
the many aspects regulated by leptin included that of the
immune system.
To further validate the role of bacterial translocation on the
control of glucose metabolism, we took advantage of a treatment
with the probiotic strain Biﬁdobacterium lactis 420, which has
been shown to exclude other bacteria from the mucosa (Collado
et al, 2007) and to improve the integrity of the epithelial cell layer
(Putaala et al, 2008). Hence, we expected to reduce the bacterial
translocation process by the probiotic treatment. A one-month
treatment markedly reduced the gram-negative bacteria E. coli
adherence to intestinal mucosa and the translocation of
Enterobacteriaceae, the bacterial group to which E. coli belongs,
in particular into MAT. Accordingly, inﬂammation, insulin
sensitivity, and fasted hyperinsulinemia were almost completely
normalized. This impacted the overall glycemic control since
glucose intolerance was reduced, although moderately, in the
probiotic-treated HFD-fed mice when compared with non-treated
HFD-fed mice. Our data suggest that the reversal of diabetes by
probiotic treatment required ﬁrst a normalization of mucosal
dysbiosis,which wasfollowed by reducedbacterial translocation,
tissueinﬂammation, insulin resistance, andsecondarilyglycemia.
Our results further validate the conclusion that a reduction in
bacterial translocation and mucosal dysbiosis helps to control the
development of metabolic diseases and opens the way to a new
probiotic strategy for the treatment of diabetes and obesity.
However, we did not observe a dramatic increase in the
concentration of Biﬁdobacterium spp. in the mucosa of HFD-
fed treated mice when compared with non-treated mice. This was
expected since we previously described that fat-diet strongly
reduces the amount of the Biﬁdobacterium genus (Cani et al,
2008). Therefore, the mechanisms through which the probiotic
regulates glucose metabolism do not seem to be related to an
increased mucosal concentration of the probiotic and hence
remain yet to be discovered. Recent data showed that some
Biﬁdobacterium species can increase production of acetate and
inhibit the translocation of the pathogenic E. coli O157:H7 Shiga
toxin from the gut lumen to the blood (Fukuda et al, 2011). Our
data here show that the bacterial translocation of commensal
bacteria is indeed reduced by the probiotic treatment arguing
for a similar mechanism, which has been described in other
instances (Fukuda et al, 2011). We cannot rule out that an acute
administration of probiotic could have a direct impact on
inﬂammation, therefore a similar reasoning could be made with
regards to the gavage of E. coli. However, we do not have any
evidence for this assumption.
In conclusion, we have discovered that a fat-enriched diet
induces a low-grade infection before the onset of diabetes. This
infection targets the MAT through a mechanism described as
bacterial translocation. This mechanism requires the recogni-
tion of PAMPs by CD14, signalling through Myd88 and is leptin-
regulated. Therefore, our data demonstrate that the increased
bacterial translocation of gram-negative bacteria into the
adipose tissue is mostly responsible for the continuous fuelling
of inﬂammatory antigens thus characterizing the origin of the
low-grade inﬂammation during diabetes and obesity. This
concept opens up avenues for the treatment of metabolic
diseases using probiotic strategies.
MATERIALS AND METHODS
Animals and diets
C57bl6, ob/ob, CD14
 / , ob/obxCD14
 / , Myd88
 / , Nod1
 /  or
Nod2
 /  mice were fed with either a normal chow diet (NC) or a HFD
(Safe, Augy, France) and the diabetic phenotype studied. This diet was
previously demonstrated to generate fasting hyperglycemia, glucose
intolerance, and insulin resistance following one month of feeding
(Burcelin et al, 2002; Riant et al, 2009). All of the animal experimental
procedures were validated by the local ethical committee of the
Rangueil Hospital.
Generation of ampicillin-resistant GFP-E. coli
An Escherichia coli was isolated from mouse cæcum (Inserm U1048)
and transformed with the plasmid pZE1R-GFP (gift from J. Oberto,
CNRS UMR8621, Orsay, France) to induce the expression of green
fluorescent protein (GFP) and b-lactamase conferring resistance to
100mg/ml of ampicillin.
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The bacterium strain Lactococcus lactis leptin (L. lactis leptin),
expressing and secreting active human leptin, was generated by
Bermu ´dez-Humara ´n and colleagues (INRA, Jouy en Josas, France) as
previously described (Bermudez-Humaran et al, 2007). Briefly, the
food-grade lactic acid bacterium Lactococcus lactis strain NZ9000 was
transformed with a plasmid allowing the expression of mature human
leptin under the control of inducible promoter (PnisA). As a negative
control, the same L. lactis strain was transformed with the same
plasmid lacking only the leptin-coding sequence.
Lactococcus lactis and L. Lactis leptin were grown in M17 (Sigma-
Aldrich, France) supplemented with 1% glucose at 308C without
shaking. Mice were orally treated with 10
9cfu/day of L. Lactis leptin or
L. Lactis resuspended in sterile PBS.
Quantification of GFP-E. coli translocation towards
mesenteric adipose tissue and mesenteric lymph nodes and
adherence to intestinal mucosa
Two or five hours after gavage with 10
9 GFP-E. coli, mice were sacrificed.
Mesenteric adipose tissue (MAT) and corresponding lymph nodes (MLN)
were harvested, luminal and mucosal contents of each intestinal
segment were separated.Tissues were then homogenized in Luria Broth
(LB), plated onto ampicillin-supplemented (100mg/ml) LB agar, and
yellow colonies were enumerated after overnight incubation at 378C.
Quantification of bacterial DNA in intestine, blood and
mesenteric adipose tissue by qPCR
Genomic DNA was isolated from blood, MAT, MLN or intestine
(contents and mucosa). All bacterial DNA was quantified by
quantitative real-time PCR targeting conserved regions of the 16S
rRNA gene, with bacterial DNA as standard template for absolute
quantification (for details see Supporting information).
Quantification of pro-inflammatory markers expression by
RT-qPCR
Total RNAs from liver, muscle (vast lateralis)a n dM A Tw e r e
prepared, reverse transcripted, and submitted to qPCR targeting
TNF-a, IL-1b, PAI-1, IFN-g and IL-6 genes, with RPL19 as house-
keeping gene for relative quantification (for details see Supporting
information).
Statistical analysis
Data were analysed by using Prism GraphPad version 5.01 (GraphPad
Software Inc., California, USA). All data are expressed as mean
 standard error of the mean (SEM). For comparison of two groups,
Student’s t-test was used. For comparison of more than two groups,
ANOVA was performed followed by posthoc with Bonferroni’s multiple
comparison test to determine significance between groups. For linear
regression analysis, significance of the correlation was determined
by Pearson’s test. Statistical difference was considered significant
when p<0.05.
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The paper explained
PROBLEM:
We are facing an epidemic of metabolic diseases, which the
classical pharmacological strategies have failed to overcome.
Hence, new paradigms are required. We have previously shown
that bacterial fragments such as lipopolysaccharides (LPS) are
present in increased amounts in the blood of diabetic mice, and
induce adipose tissue inflammation, which is the first step
leading to insulin resistance and adipose tissue expansion,
resulting in obesity. Our previous data suggested that targeting
mechanisms involved in the recognition of bacterial fragments
could be an original therapeutic strategy to overcome the low-
grade inflammation and the development of metabolic diseases.
Here, we aimed at identifying such mechanisms.
RESULTS:
We show that at the early onset of HFD-induced diabetes and
obesity, the mucosal adherence of commensal bacteria is
increased dramatically in the mouse intestine. This is accom-
paniedby anaugmentation ofthe translocation of thesebacteria
into the adipose tissue. These living bacteria then co-localized
with dendritic cells of the intestinal lamina propria and the
mesenteric lymph nodes when diabetes is established. Impor-
tantly, we demonstrate that this mechanism requires CD14 and
Nod1, which are receptors that recognize different fragments of
gram-negative bacteria. Furthermore, leptin reduces intestinal
mucosal adherence and translocation of bacteria, since in the
absence of the hormone, the mice are dramatically obese and
inflamed. Finally, to overcome the bacterial translocation, we
used a probiotic treatment and showed that glucose metabolism
was indeed improved, demonstrating the importance of the
control of intestinal adherence and translocation of commensal
bacteria in the regulation of metabolic diseases.
IMPACT:
We thus propose a new paradigm for the treatment of metabolic
disease. We suggest that targeting intestinal bacterial adher-
ence, bacterial translocation, or receptors of bacterial fragments
would be an original and novel strategy to prevent or reverse the
occurrence of metabolic diseases. Therefore, new probiotics,
which aim to target this function, can be defined.
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analysed the data, contributed to discussion, wrote and edited
the paper.
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